Afrezza is the first needle-free form of insulin FDA-approved for pediatric patients.

The FDA has approved technosphere insulin, an inhaled form of human insulin, for children and adolescents aged 6 years and older with type 1 and type 2 diabetes, according to an…

Afrezza is the first needle-free form of insulin FDA-approved for pediatric patients.